Keyphrases
Oxaliplatin
100%
Time to Treatment Failure
100%
Calcium Salts
50%
Magnesium Salts
50%
Hazard Ratio
20%
Tumor Response
20%
Neurotoxicity
20%
Treatment Failure
20%
Data Monitoring Committee
20%
Significant Benefit
10%
Integral Component
10%
Dosing Schedule
10%
Treatment Effect
10%
Placebo
10%
Time-to-treatment
10%
Treatment Duration
10%
Tumor Progression
10%
Treatment Schedule
10%
Prevention Trials
10%
No Adverse Effect
10%
Colorectal Cancer Prevention
10%
Time to Tumor Progression
10%
Study Termination
10%
Bevacizumab
10%
Response Evaluation Criteria in Solid Tumors (RECIST)
10%
Oxaliplatin Neurotoxicity
10%
Radiology Review
10%
Double Randomization
10%
Medicine and Dentistry
Time to Treatment
100%
Oxaliplatin
100%
Magnesium Salt
45%
Calcium Salt
45%
Neurotoxicity
27%
Neoplasm
18%
Hazard Ratio
18%
Tumor Progression
18%
Cancer Therapy
9%
Infusion
9%
Placebo
9%
Adverse Event
9%
Radiology
9%
Colorectal Carcinoma
9%
Response Evaluation Criteria in Solid Tumors
9%
Bevacizumab
9%
Treatment Duration
9%
Pharmacology, Toxicology and Pharmaceutical Science
Oxaliplatin
100%
Calcium Salt
45%
Magnesium Salt
45%
Neurotoxicity
27%
Neoplasm
18%
Tumor Growth
18%
Placebo
9%
Solid Malignant Neoplasm
9%
Adverse Event
9%
Colorectal Carcinoma
9%
Bevacizumab
9%